Evidence map›Paper›PMID 42332748›Full record

ArticleJournal of neuroinflammation2026

Gasdermin D-dependent neutrophil pyroptosis exacerbates Coxsackievirus A6-induced neuroinflammation through NET formation.

Quanman Hu, Dong Li, Yaqi Xie, Fang Wang, Tiantian Sun, Wangquan Ji, Peiyu Zhu, Jinzhao Long, Haiyan Yang, Shuaiyin Chen and 2 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Quanman HuCollege of Public Health, Zhengzhou University, Zhengzhou, 450001, China.
Dong LiSchool of Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Yaqi XieZhengzhou Center for Disease Control and Prevention, Zhengzhou, 450007, China.
Fang WangDepartment of Infectious Diseases, Children's Hospital, Zhengzhou University, Zhengzhou, 450018, China.
Tiantian SunDepartment of Infection Control, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, 450003, China.
Wangquan JiCollege of Public Health, Zhengzhou University, Zhengzhou, 450001, China.
Peiyu ZhuCollege of Public Health, Zhengzhou University, Zhengzhou, 450001, China.
Jinzhao LongCollege of Public Health, Zhengzhou University, Zhengzhou, 450001, China.
Haiyan YangCollege of Public Health, Zhengzhou University, Zhengzhou, 450001, China.
Shuaiyin ChenCollege of Public Health, Zhengzhou University, Zhengzhou, 450001, China. sychen@zzu.edu.cn.
Yuefei JinCollege of Public Health, Zhengzhou University, Zhengzhou, 450001, China. jyf201907@zzu.edu.cn.
Guangcai DuanCollege of Public Health, Zhengzhou University, Zhengzhou, 450001, China.

Funding

China Postdoctoral Science Foundation 2024T170246Henan Province Science and Technology Research Project 242102311147National Natural Science Foundation of China 82073618National Natural Science Foundation of China 82372229National Natural Science Foundation of China 82574168Open Grant from the Pingyuan Laboratory 2023PY-OP-0202Open Project of Henan Province Engineering Research Center of Diagnosis and Treatment of Pediatric Infection and Critical Care ERC202302Open Project of Key Laboratory of Children's Disease Research in Guangxi's Colleges and Universities GXCDR202401Open Project of Key Laboratory of Infection and Immunity of Anhui Higher Education Institutes I&I-2024-R01Outstanding Youth Science Foundation of Henan Province 252300421122Program for Innovative Talents in Higher Education Institutions of Henan Province 25HASTIT055Zhengzhou Science and Technology Beneficiary Program Project 2022KJHM0004
6 · The paper itself

Abstract

backgroundCoxsackievirus A6 (CVA6) is a nonenveloped, single-stranded RNA virus linked to neurological complications. Emerging evidence suggests neutrophil pyroptosis drives inflammation. However, the role of neutrophil pyroptosis in CVA6 pathogenesis remains unexplored.

methodsTen-day-old wild-type (WT), Caspase-1 KO, and GSDMD KO mice were infected with a lethal dose of CVA6. For in vivo and in vitro studies, we used the caspase-1 inhibitor belnacasan, disulfiram, and anti-Ly6G antibody. We also generated neutrophil-specific PAD4-knockout mice (PAD4 Ne-KO) by deleting Padi4 under the S100A8 promoter. Post-infection, clinical scores, survival, and body weight were monitored. Brain tissues and bone marrow-derived neutrophils (BMDNs) were collected for analysis. Key methods included qPCR, Western blotting, histology/immunofluorescence, flow cytometry, and TEM to assess pyroptosis, inflammation, and immune cell infiltration. Findings were further validated using blood samples from HFMD patients.

resultsIn this study, we investigated how the Caspase-1/GSDMD pathway mediates neutrophil extracellular trap (NET) release and drives CVA6-induced neuroinflammation. CVA6 infection increased neutrophil numbers in mouse brain and peripheral blood, along with elevated MPO-DNA-a NET marker. In BMDNs, degranulation and NET formation occurred by 24 hpi, accompanied by Caspase-1/GSDMD activation. Caspase-1 knockout prolonged survival and reduced GSDMD-N expression in brain neutrophils; pharmacological Caspase-1 inhibition decreased mature IL-1β and IL-18 in brain tissue and suppressed CVA6 replication in BMDNs. Together, in vitro and in vivo data indicate that Caspase-1/GSDMD activation and NETosis critically contribute to CVA6-induced brain injury. This was confirmed by GSDMD knockout or disulfiram-mediated GSDMD inhibition, both of which markedly reduced NET release and neuropathology. Notably, global neutrophil depletion worsened infection-suggesting a protective role-whereas neutrophil-specific PAD4 knockout improved survival. Clinically, GSDMD expression showed a significant positive correlation with NETosis markers in patient samples from CVA6-infected individuals.

conclusionThese findings enhance understanding of enteroviral pathogenesis, identify GSDMD as a promising therapeutic target, and provide a novel framework for developing precision interventions that reduce excessive inflammation without impairing essential host defenses.

Indexed as

Coxsackievirus InfectionsEnterovirusExtracellular TrapsIntracellular Signaling Peptides and ProteinsNeuroinflammatory DiseasesNeutrophilsPhosphate-Binding ProteinsPyroptosisAnimalsCaspase 1FemaleGasderminsHumansMaleMiceMice, Inbred C57BLCaspase 1GasderminsGsdmd protein, mouseIntracellular Signaling Peptides and ProteinsPhosphate-Binding ProteinsCVA6Gasdermin DNETsNeuroinflammationNeutrophil pyroptosis

Identifiers

PMID42332748
PMCPMC13339694

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.